CommentaryCommentary On: “Examining the Role of Retrobulbar Hyaluronidase in Reversing Filler Induced Blindness: A Systematic Review,” by Paap MK, Milman T, Ugradar S, Goldberg R, Silkiss RZCarruthers, Jean D. A. M.D.*; Carruthers, J. Alastair M.D.†; Fagien, Steven M.D.‡Author Information *Department of Ophthalmology and Visual Science, University of British Columbia †Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, British Columbia, Canada ‡Aesthetic Oculoplastic Surgery, Boca Raton, Florida, U.S.A. Accepted for publication January 31, 2020. JC is a researcher with Alastin, a Consultant and Researcher with Allergan, Bonti, Merz, Revance, Alphaeon, an Assistant Editor of Dermatologic Surgery, Author, and Editor at Elsevier (royalties). AC is retired and an Assistant Editor of Dermatologic Surgery and is a consultant for Allergan and Mertz. SF is a Consultant and Clinical Investigator for Allergan, Galderma, Revance, Evolus, Alastin. Address correspondence and reprint requests to Jean Carruthers, M.D., Carruthers Cosmetic Surgery, 943 West Broadway, Suite 820, Vancouver, BC, V5Z4E1, Canada. E-mail:firstname.lastname@example.org Ophthalmic Plastic and Reconstructive Surgery: May/June 2020 - Volume 36 - Issue 3 - p 239-240 doi: 10.1097/IOP.0000000000001628 Buy Metrics © 2020 The American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc.